Active Ingredient: CRINECERFONT
Proprietary Name: CRENESSITY
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: 50MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N218820
Product Number: 001
Approval Date: Dec 13, 2024
Applicant Holder Full Name: NEUROCRINE BIOSCIENCES INC
Marketing Status:
Prescription
Patent and Exclusivity Information